Autobio Diagnostics Co Stock

Autobio Diagnostics Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Autobio Diagnostics Co (603658.SS) as of Aug 15, 2026 is 17.16. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 16.62 — a change of 3.26% (higher).

EV/EBIT

17.16

YoY

3.26%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Autobio Diagnostics Co is 2026 17.16 . EV/EBIT (Enterprise Value to EBIT) of Autobio Diagnostics Co was 2025 16.62 . It decreases by 3.26% higher compared to the previous year.

The Autobio Diagnostics Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
44.94 base
Jan 1, 2020
75.51 base
Jan 1, 2021
32.88 base
Jan 1, 2022
30.72 base
Jan 1, 2023
26.63 base
Jan 1, 2024
20.90 base
Jan 1, 2025 (e)
14.96 base
Jan 1, 2026 (e)
12.46 base
YEARPRICE-TO-EBIT
2026 est 12.46
2025 est 14.96
2024 20.90
2023 26.63
2022 30.72
2021 32.88
2020 75.51
2019 44.94
2018 31.84
2017 46.25
2016 56.67
2015 -
2014 -
2013 -
Access this data via the Eulerpool API
Get Free API Key

Autobio Diagnostics Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Autobio Diagnostics Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Autobio Diagnostics Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Autobio Diagnostics Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Autobio Diagnostics Co grows earnings faster than its peers.

Autobio Diagnostics Co Stock analysis

What does Autobio Diagnostics Co do? Autobio Diagnostics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Autobio Diagnostics Co stock

EV/EBIT (Enterprise Value to EBIT) of Autobio Diagnostics Co is 17.16 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Autobio Diagnostics Co changed from 16.62 to 17.16, representing a 3.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Autobio Diagnostics Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Autobio Diagnostics Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Autobio Diagnostics Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Autobio Diagnostics Co